Literature DB >> 19682469

Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.

Luc Zimmer1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder characterized by inappropriate symptoms of inattention, impulsivity and motor restlessness. Converging data from neuropsychological, genetic, neurochemical and pharmacological studies have implicated fronto-striatal network abnormalities as the likely cause of ADHD. The functional imaging field has evolved rapidly providing unprecedented tools to examine questions regarding the pathophysiology of ADHD and the biological effects of medications used to treat it. Positron emission tomography (PET) provides unique quantitative information on the spatial resolution of radiolabelled molecules in the brain of patients or healthy subjects allowing the longitudinal assessment of physiological parameters such as binding potential over extended periods of time. The main goal of this review is to provide an overview of PET studies performed in ADHD patients, discuss their relative strengths and weaknesses and show how they can complement one another to enable a better understanding of the neurobiology and the neuropharmacology of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682469     DOI: 10.1016/j.neuropharm.2009.08.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Brain regional glucose uptake changes in isolated cerebellar cortical dysplasia: qualitative assessment using coregistrated FDG-PET/MRI.

Authors:  Patrice Jissendi-Tchofo; Florence Pandit; Louis Vallée; Mathieu Vinchon; Jean-Pierre Pruvo; Danielle Baleriaux; Gustavo Soto Ares
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates.

Authors:  Rasmus M Birn; Alexander K Converse; Abigail Z Rajala; Andrew L Alexander; Walter F Block; Alan B McMillan; Bradley T Christian; Caitlynn N Filla; Dhanabalan Murali; Samuel A Hurley; Rick L Jenison; Luis C Populin
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

Review 3.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

4.  Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Authors:  Sucharita S Somkuwar; Kathleen M Kantak; Linda P Dwoskin
Journal:  J Neurosci Methods       Date:  2015-02-11       Impact factor: 2.390

Review 5.  Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Authors:  Mark S Gold; Kenneth Blum; Marlene Oscar-Berman; Eric R Braverman
Journal:  Postgrad Med       Date:  2014-01       Impact factor: 3.840

6.  Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.

Authors:  Thomas Vanicek; Alexandra Kutzelnigg; Cecile Philippe; Helen L Sigurdardottir; Gregory M James; Andreas Hahn; Georg S Kranz; Anna Höflich; Alexander Kautzky; Tatjana Traub-Weidinger; Marcus Hacker; Wolfgang Wadsak; Markus Mitterhauser; Siegfried Kasper; Rupert Lanzenberger
Journal:  Hum Brain Mapp       Date:  2016-10-22       Impact factor: 5.038

7.  Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks.

Authors:  Felipe Schmitz; Josiane S Silveira; Gianina T Venturin; Samuel Greggio; Guilherme Schu; Eduardo R Zimmer; Jaderson Costa Da Costa; Angela T S Wyse
Journal:  Neurotox Res       Date:  2021-11-19       Impact factor: 3.911

8.  A Whole-Brain and Cross-Diagnostic Perspective on Functional Brain Network Dysfunction.

Authors:  Marjolein Spronk; Brian P Keane; Takuya Ito; Kaustubh Kulkarni; Jie Lisa Ji; Alan Anticevic; Michael W Cole
Journal:  Cereb Cortex       Date:  2021-01-01       Impact factor: 5.357

9.  PET kinetics of radiolabeled antidepressant, [N-methyl-11C]mirtazapine, in the human brain.

Authors:  Ole L Munk; Donald F Smith
Journal:  EJNMMI Res       Date:  2011-12-15       Impact factor: 3.138

10.  Gamma aminobutyric acidergic and neuronal structural markers in the nucleus accumbens core underlie trait-like impulsive behavior.

Authors:  Daniele Caprioli; Stephen J Sawiak; Emiliano Merlo; David E H Theobald; Marcia Spoelder; Bianca Jupp; Valerie Voon; T Adrian Carpenter; Barry J Everitt; Trevor W Robbins; Jeffrey W Dalley
Journal:  Biol Psychiatry       Date:  2013-08-21       Impact factor: 13.382

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.